Neonatal extracorporeal life support: Impact of new therapies on survival

Journal of Pediatrics

Volumn 148, Issue 5, 2006, Pages 595-599

  Fliman, Paola J ^a,b   deRegnier, Raye Ann O ^a,b   Kinsella, John P ^a,b   Reynolds, Marleta ^a,b   Rankin, Linda L ^a,b   Steinhorn, Robin H ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BREATHING DISORDER; CANNULATION; CARDIOPULMONARY ARREST; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; SURVIVAL;

BRONCHODILATOR AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT; INFANT, NEWBORN; NITRIC OXIDE; PULMONARY SURFACTANTS; REGISTRIES; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33646848399     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.12.024     Document Type: Article

References (25)

1. Bartlett R.H., Andrews A.F., Toomasian J.M., Haiduc N.J., and Gazzaniga A.B. Extracorporeal membrane oxygenation for newborn respiratory failure. forty-five cases. Surgery 92 (1982) 425-433
2. UK Collaborative ECMO Trial Group. UK Collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 348 (1996) 75-82
3. Wolfson P.J. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg 76 (2003) S2224-S2229
4. Lewis D.A., Gauger P., Delosh T.N., Dechert R.E., and Hirschl R.B. The effect of pre-ECLS ventilation time on survival and respiratory morbidity in the neonatal population. J Pediatr Surg 31 (1996) 1110-1115
5. Roy B.J., Rycus P., Conrad S., and Clark R. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics 106 (2000) 1334-1338
6. Hirschl R.B., and Bartlett R.H. Extracorporeal membrane oxygenation support in cardiorespiratory failure. Adv Surg 21 (1988) 189-212
7. Bartlett R.H. Extracorporeal life support for cardiopulmonary failure. Curr Probl Surg 27 (1990) 623-705
8. Hui T.T., Danielson P.D., Anderson K.D., and Stein J.E. The impact of changing neonatal respiratory management on extracorporeal membrane oxygenation utilization. J Pediatr Surg 37 (2002) 703-705
9. Wilson J.M., Bower L.K., Thompson J.E., Fauza D.O., and Fackler J.C. ECMO in evolution. the impact of changing patient demographics and alternative therapies on ECMO. J Pediatr Surg 31 (1996) 1116-1123
10. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336 (1997) 597-604
11. Roberts J.D., Fineman J.R., Morin F.C., Shaul P.W., Rimar S., Schreiber M.D., et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336 (1997) 605-610
12. Kinsella J.P., Truog W.E., Walsh W.F., Goldberg R.N., Bancalari E., Mayock D.E., et al. Randomized, multicenter trial of inhaled nitric oxide and high frequency ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 124 (1994) 447-454
13. Clark R.H., Yoder B.A., and Sell M.S. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 124 (1994) 447-454
14. Auten R.L., Notter R.H., Kendig J.W., Davis J.M., and Shapiro D.L. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87 (1991) 101-107
15. Findlay R.D., Taeusch H.W., and Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97 (1996) 48-52
16. Lotze A., Mitchell B.R., Bulas D.I., Zola E.M., Shalwitz R.A., Gunkel J.H., and Survanta in Term Infants Study Group. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 132 (1998) 40-47
17. Kennaugh J.M., Kinsella J.P., Abman S.H., Hernandez J.A., Moreland S.G., and Rosenberg A.A. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol 17 (1997) 366-369
18. Haase G.M., Kennaugh J.M., and Clarke D.R. Adaptation of an ECMO team in the era of successful alternative therapies for neonatal pulmonary failure. J Pediatr Surg 30 (1995) 674-678
19. Hintz S.R., Suttner D.M., Sheehan A.M., Rhine W.D., and Van Meurs K.P. Decreased use of neonatal extracorporeal membrane oxygenation and how new treatment modalities have affected ECMO utilization. Pediatrics 106 (2000) 1339-1343
20. Gill B.S., Neville H.L., Khan A.M., Cox Jr. C.S., and Lally K. Delayed institution of extracorporeal membrane oxygenation is associated with increased mortality rate and prolonged hospital stay. J Pediatr Surg 37 (2002) 7-10
21. Extracorporeal Life Support Organization. ECLS Registry Report International Summary (2004), Extracorporeal Life Support Organization, Ann Arbor, Mich 1-2 January
22. American Academy of Pediatrics. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99 (1997) 489-496
23. Van Meurs K., and Congenital Diaphragmatic Hernia Study Group. Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?. J Pediatr 145 (2004) 312-316
24. Lotze A., Knight G.R., Martin G.R., Bulas D.I., Hull W.M., O'Donnell R.M., et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 122 (1993) 261-268
25. Colby C.E., and Congenital Diaphragmatic Hernia Study Group. Surfactant replacement therapy on ECMO does not improve outcome in neonates with congenital diaphragmatic hernia. J Pediatr Surg 39 (2004) 1632-1637